We had the pleasure of speaking with Odette Hauke at last week’s Psychedelic Therapeutics & Drug Development Conference in New Orleans. We discussed how FDA regulatory and submission protocols are evolving, particularly with the growing integration of AI into drug development and review processes. Conducted as part of Cascades Analytics’ conference coverage, in partnership with Arrowhead SciTech Conferences & Events.